These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley. Skoglund B Acta Orthop Suppl; 2007 Dec; 78(328):3-22. PubMed ID: 18283564 [No Abstract] [Full Text] [Related]
43. Sol-gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia. Linderbäck P; Areva S; Aspenberg P; Tengvall P J Biomed Mater Res A; 2010 Aug; 94(2):389-95. PubMed ID: 20186735 [TBL] [Abstract][Full Text] [Related]
44. The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model. Hattori T; Fei W; Kizawa T; Nishida S; Yoshikawa H; Kishida Y Phytomedicine; 2010 Mar; 17(3-4):170-7. PubMed ID: 20097049 [TBL] [Abstract][Full Text] [Related]
46. Bioerodible devices for intermittent release of simvastatin acid. Jeon JH; Thomas MV; Puleo DA Int J Pharm; 2007 Aug; 340(1-2):6-12. PubMed ID: 17433584 [TBL] [Abstract][Full Text] [Related]
47. [Transdermal delivery of cyclosporin A solubilized in mixed micelles through mice skin]. Wu T; Guo JX; Ping QN; Jin FY; Sun XW Yao Xue Xue Bao; 2001 May; 36(5):381-5. PubMed ID: 12584864 [TBL] [Abstract][Full Text] [Related]
48. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system. Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787 [TBL] [Abstract][Full Text] [Related]
49. Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis. Yasui T; Itoh Y; Okada A; Hamamoto S; Hirose M; Kobayashi T; Tozawa K; Kohri K Urol Int; 2009; 83(2):226-9. PubMed ID: 19752622 [TBL] [Abstract][Full Text] [Related]
50. Bone-protective effects of bioactive fractions and ingredients in Sambucus williamsii HANCE. Xiao HH; Dai Y; Wan HY; Wong MS; Yao XS Br J Nutr; 2011 Dec; 106(12):1802-9. PubMed ID: 21736773 [TBL] [Abstract][Full Text] [Related]
51. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Tiwari R; Pathak K Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809 [TBL] [Abstract][Full Text] [Related]
52. Control of surface topography in biomimetic calcium phosphate coatings. Costa DO; Allo BA; Klassen R; Hutter JL; Dixon SJ; Rizkalla AS Langmuir; 2012 Feb; 28(8):3871-80. PubMed ID: 22242934 [TBL] [Abstract][Full Text] [Related]
53. Simvastatin application to augment facial jaw bone in a dog model: pilot study. Rutledge J; Schieber MD; Chamberlain JM; Byarlay M; Killeen AC; Giannini PJ; Marx DB; Reinhardt RA J Periodontol; 2011 Apr; 82(4):597-605. PubMed ID: 21043796 [TBL] [Abstract][Full Text] [Related]
54. The influence of local administration of simvastatin in calvarial bone healing in rats. Calixto JC; Lima CE; Frederico L; Lima RP; Anbinder AL J Craniomaxillofac Surg; 2011 Apr; 39(3):215-20. PubMed ID: 20456964 [TBL] [Abstract][Full Text] [Related]
55. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779 [TBL] [Abstract][Full Text] [Related]
56. Calcium phosphate cement delivering zoledronate decreases bone turnover rate and restores bone architecture in ovariectomized rats. Wu CC; Wang CC; Lu DH; Hsu LH; Yang KC; Lin FH Biomed Mater; 2012 Jun; 7(3):035009. PubMed ID: 22419030 [TBL] [Abstract][Full Text] [Related]
57. Impact of local and systemic alendronate on simvastatin-induced new bone around periodontal defects. Killeen AC; Rakes PA; Schmid MJ; Zhang Y; Narayana N; Marx DB; Payne JB; Wang D; Reinhardt RA J Periodontol; 2012 Dec; 83(12):1463-71. PubMed ID: 22420870 [TBL] [Abstract][Full Text] [Related]
58. Biomineralization inspired surface engineering of nanocarriers for pH-responsive, targeted drug delivery. Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X Biomaterials; 2013 Jan; 34(4):1364-71. PubMed ID: 23140999 [TBL] [Abstract][Full Text] [Related]
59. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Shin HD; Yang KJ; Park BR; Son CW; Jang HJ; Ku SK Nutrition; 2007; 23(11-12):853-60. PubMed ID: 17884343 [TBL] [Abstract][Full Text] [Related]
60. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Hughes A; Rogers MJ; Idris AI; Crockett JC Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]